These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 16286247)

  • 1. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
    Varambally S; Yu J; Laxman B; Rhodes DR; Mehra R; Tomlins SA; Shah RB; Chandran U; Monzon FA; Becich MJ; Wei JT; Pienta KJ; Ghosh D; Rubin MA; Chinnaiyan AM
    Cancer Cell; 2005 Nov; 8(5):393-406. PubMed ID: 16286247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systems approach to model metastatic progression.
    Taylor BS; Varambally S; Chinnaiyan AM
    Cancer Res; 2006 Jun; 66(11):5537-9. PubMed ID: 16740685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential proteomic alterations between localised and metastatic prostate cancer.
    Taylor BS; Varambally S; Chinnaiyan AM
    Br J Cancer; 2006 Aug; 95(4):425-30. PubMed ID: 16880794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.
    Khan AP; Poisson LM; Bhat VB; Fermin D; Zhao R; Kalyana-Sundaram S; Michailidis G; Nesvizhskii AI; Omenn GS; Chinnaiyan AM; Sreekumar A
    Mol Cell Proteomics; 2010 Feb; 9(2):298-312. PubMed ID: 19955085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of spermidine/spermine N(1) -acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis.
    Huang W; Eickhoff JC; Mehraein-Ghomi F; Church DR; Wilding G; Basu HS
    Prostate; 2015 Aug; 75(11):1150-9. PubMed ID: 25893668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational methods for comparison of large genomic and proteomic datasets reveal protein markers of metastatic cancer.
    Wang Y; Hanley R; Klemke RL
    J Proteome Res; 2006 Apr; 5(4):907-15. PubMed ID: 16602698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endosomal gene expression: a new indicator for prostate cancer patient prognosis?
    Johnson IR; Parkinson-Lawrence EJ; Keegan H; Spillane CD; Barry-O'Crowley J; Watson WR; Selemidis S; Butler LM; O'Leary JJ; Brooks DA
    Oncotarget; 2015 Nov; 6(35):37919-29. PubMed ID: 26473288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
    Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
    Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative molecular concept modeling of prostate cancer progression.
    Tomlins SA; Mehra R; Rhodes DR; Cao X; Wang L; Dhanasekaran SM; Kalyana-Sundaram S; Wei JT; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Nat Genet; 2007 Jan; 39(1):41-51. PubMed ID: 17173048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.
    Lin D; Watahiki A; Bayani J; Zhang F; Liu L; Ling V; Sadar MD; English J; Fazli L; So A; Gout PW; Gleave M; Squire JA; Wang YZ
    Cancer Res; 2008 Jun; 68(11):4352-9. PubMed ID: 18519696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
    Reyes I; Tiwari R; Geliebter J; Reyes N
    Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy.
    Klein EA; Yousefi K; Haddad Z; Choeurng V; Buerki C; Stephenson AJ; Li J; Kattan MW; Magi-Galluzzi C; Davicioni E
    Eur Urol; 2015 Apr; 67(4):778-86. PubMed ID: 25466945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.
    Schulz WA; Alexa A; Jung V; Hader C; Hoffmann MJ; Yamanaka M; Fritzsche S; Wlazlinski A; Müller M; Lengauer T; Engers R; Florl AR; Wullich B; Rahnenführer J
    Mol Cancer; 2007 Feb; 6():14. PubMed ID: 17280610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of microarray-derived genetic signatures in predicting outcomes in prostate cancer.
    Reddy GK; Balk SP
    Clin Genitourin Cancer; 2006 Dec; 5(3):187-9. PubMed ID: 17239271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men.
    Ross AE; Johnson MH; Yousefi K; Davicioni E; Netto GJ; Marchionni L; Fedor HL; Glavaris S; Choeurng V; Buerki C; Erho N; Lam LL; Humphreys EB; Faraj S; Bezerra SM; Han M; Partin AW; Trock BJ; Schaeffer EM
    Eur Urol; 2016 Jan; 69(1):157-65. PubMed ID: 26058959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR2 expression correlates with prostate cancer progression.
    Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
    J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling predicts clinical outcome of prostate cancer.
    Glinsky GV; Glinskii AB; Stephenson AJ; Hoffman RM; Gerald WL
    J Clin Invest; 2004 Mar; 113(6):913-23. PubMed ID: 15067324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.